<div class="chapter-header">
	<div class="white-sheet">
		
		<div class="title-bar red"></div>

		<div class="wrapper slide-sa_head">

			<div class="nav">
				<button class="blue active arrow_box navigate" data-navtarget="mod_2_home">MODULE 2</button>

				<button class="blue arrow_box navigate" data-navtarget="slide_g_1_2">GLOSSARY</button>

				<button class="blue arrow_box active navigate" data-navtarget="slide_sa_2">SELF-ASSESSMENT</button>
				
				<button class="blue arrow_box show-overlay" data-effect="fade" data-duration="1000" data-target="learning-objectives-overlay" data-width="600" data-height="490">LEARNING OBJECTIVES</button>

			</div>

			<div class="chapter-title one-line">
				<div class="chapter-num">SA2</div>
				<div class="title-1">Module 2: Self-assessment</div>
			</div>

			<button class="big-blue navigate" data-navtarget="slide_sa2">ENTER</button>

			<div class="learning-objectives-overlay overlay">

				<header>Learning Objectives</header>
					
				<ul>
					<li><span>By the end of this module you should be able to:</span>
						<ul>
							<li><span>Explain what aplastic anaemia is and differentiate between the main types of disease</span>
								<ul>
									<li><span>To understand the new proposed indication for eltrombopag for the treatment of this condition</span></li>
								</ul>
							</li>
							<li><span>Describe the pathophysiology of acquired aplastic anaemia</span>
								<ul>
									<li><span>It is thought that acquired aplastic anaemia arises from autoimmune destruction of haematopoietic stem cells (HSCs)</span></li>
								</ul>
							</li>
							<li><span>Discuss the current standards of care for severe aplastic anaemia and their advantages andÂ limitations</span>
								<ul>
									<li><span>To recognise the unmet needs in the management of severe aplastic anaemia
									</span></li>
								</ul>
							</li>
						</ul>
					</li>
				</ul>

			</div>

		</div>

	</div>
</div>
